References
- Kandall S R, Albin S, Lowinson J, Berle B, Eidelman A I, Gartner L M. Differential effects of maternal heroin and methadone use on birthweight. Pediatrics 1976; 58: 681–685
- Svikis D, Golden A, Huggins G, Pickens R W, McCaul M E, Velez M, Rosendale T, Brooner R, Gazaway P, Stitzer M. Cost-effectivness of comprehensive care for drug abusing pregnant women. Drug Alcohol Depend 1997; 45: 105–113
- Jasinski D R, Pevnick J S, Griffith J D. Human pharmacology and abuse potential of the analgesic buprenorphine: a potential agent for treating narcotic addiction. Arch Psychiatry 1978; 35: 501–516
- Johnson R E, Jones H E, Fisher G. Use of buprenorphine in pregnancy: patient management and effects on the neonate. Drug Alcohol Depend 2003; 70: S87–S101
- Jones H E, Johnson R E, Jasinski D R, O'Grady K E, Chisholm C A, Choo R E, Crocetti M, Dudas R, Harrow C, Huestis M A. Buprenorphine versus methadone in the treatment of pregnant opioid-dependent patients: effects on the neonatal abstinent syndrome. Drug Alcohol Depend 2005; 79: 1–10
- Auriacombe M, Afflelou S, Lavignasse P, Lafitte C, Roux D, Daulouede J P, Tignol J. Pregnancy, abortion, and delivery in a cohort of heroin-dependent patients treated with drug substitution (methadone and buprenorphine) in aquitaine. Presse Med 1999; 28: 177
- Rohrmeister K, Bernert G, Langer M, Fisher G, Weninger M, Pollak A. Opiate addiction in gravidity-consequences for the newborn. Results on an interdisciplinary treatment concept. Z Geburtshilfe Neonatol 2001; 205: 224–230
- Nanovskaya T N, Deshmukh S, Brooks M, Ahmed M. Transplacental transfer and metabolism of buprenorphine. J Pharmacol Exp Ther 2002; 3: 26–33
- Deshmukh S V, Nanovskaya T N, Ahmed M S. Aromatse is the major enzyme metabolizing buprenorphine in human placenta. J Pharmacol Exp Ther 2003; 306: 1099–1105
- Kobayashi K, Yamamoto T, Chiba K, Tani M, Shimada N, Ishizaki T, Kuroiwa Y. Human buprenorphine N-dealkylation is catalyzed by cytochrome P450 3A4. Drug Metab Dispos 1998; 26: 818–822
- Nekhayeva I A, Nanovskaya T N, Hankins G DV, Ahmed M S. Role of human placental efflux transporter P-glycoprotein in the transfer of buprenorphine, Levo-α-acetylmethadol, and paclitaxel. Am J Perinatol 2006; 23: 423–430
- Takahashi Y, Ishii S, Arizono H, Nishimura S, Tsuruda K, Saito N, nemoto H, Jin Y, Esumi Y. Pharmacokinetics of buprenorphine hydrochloride. Absorption, distribution, metabolism, excretion after percutaneous or subcutaneous administration of buprenorphine hydrochloride in rats. Xenobiotic Metabolism and Disposition 2001; 16: 569–583
- Hytten F E, Leitch I. The physiology of human pregnancy. Blackwell Scientific Publications, Oxford 1971
- Pritchard J A, Macdonald P C. Williams obstetrics15th ed. Appleton-Century-Crofts, New York 1976
- Krauer B, Dayer P, Anner R. Changes in serum albumin and alpha 1-acid glycoprotein concentrations during pregnancy: an analysis of fetal-maternal pairs. Br J Obstet Gynecol 1984; 91: 875–881
- Hill M D, Abramson F P. The significance of plasma protein binding on the fetal/maternal distribution of drugs at steady-state. Clin Pharmacokinet 1988; 14: 156–170
- McNamara P J, Alcorn J. Protein binding predictions in infants. AAPS PharmSci Serial Online 2002; 41, Available at: http://www.aapspharmsci.org/view.asp?art=ps040104. Last accessed 8 May 2008
- Miller R K, Wier P J, Maulik D, di Sant'Agnese P A. Human placenta in vitro: characterization during 12 h of dual perfusion. Contrib Gynec Obstet 1985; 13: 77–84
- Walsh S L, Preston K L, Stitzer M L, Cone E J, Bigelow G E. Clinical pharmacology of buprenorphine: ceiling effects at high doses. Clin Pharmacol Ther 1994; 55: 569–580
- Jagsch R, Gombas W, Schindler S H, Eder H, Moody D E, Fischer G. Opioid plasma concentrations in methadone-and buprenorphine-maintained patients. Addict Biol 2005; 10: 365–371
- Schneider H. Techniques: in vitro perfusion of human placenta. Placental toxicology, B VR Sastry. CRC Press, Boca Raton 1995; 1–26
- Sastry B VR. Technique to study human placental transport. Adv Drug Deliv Rev 1999; 38: 17–39
- Nanovskaya T N, Patrikeeva S, Hemauer S, Fokina V, Mattison D R, Hankins G DV, Ahmed M S. Effect of albumin on transplacental transfer and distribution of rosiglitazone and glyburide. J Matern Fetal Neonatal Med 2008; 21: 197–207